Revenue of Sanofi from 2006 to 2018
(in million euros)
Revenue of Sanofi 2006-2018
Sanofi is a global leader in healthcare and pharmaceuticals based in Paris, France. In 2018, Sanofi generated about 34.5 billion euros in revenues. Sanofi’s modern revenues were highest in 2017 when the company earned just over 35 billion euros. In general, the company’s revenues have been increasing since 2006 when their revenues were 28.4 billion euros.

Sanofi’s company profile

Sanofi is a one of the world’s leading pharmaceutical companies and its subsidiaries include Genzyme, Sanofi Pasteur and Aventis Pharma, to name a few. Sanofi is ranked among the top ten global pharmaceutical companies based on market capitalization. Likewise, the company is ranked among the top six global pharmaceutical companies based on its prescription sales.

Sanofi’s products and revenues

Sanofi works in several therapeutic sectors including health and wellbeing, diabetes and cardiovascular diseases, oncology, immunology, multiple sclerosis, rare diseases, rare blood disorders, and vaccines. A majority of Sanofi’s revenues can be attributed to their pharmaceutical sector. Sanofi’s top pharmaceutical products, based on revenues include Lantus, Aubagio and Lovenox. Lantus is a long-acting insulin for use in type I and type II diabetes. Sanofi also used to have an animal health sector but the business was sold to Boehringer Ingelheim in 2016.
Revenue of Sanofi from 2006 to 2018
(in million euros)
Revenue in million euros
201834,463
201735,072
2016**33,809
201534,060
201431,380
201330,693
2012*34,743
2011*33,389
201032,367
200929,785
200827,568
200728,052
200628,373
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2019

Region

Worldwide

Survey time period

2006 to 2018

Supplementary notes

Figures for 2006-2013 were quoted from previous annual reports.
* Including the Animal Health business, the net income/loss of which is presented in a separate line item. For 2012 and 2011, it is not practicable to provide information excluding the Animal Health business without unreasonable effort or expense.
** Due to a change in accounting presentation, VaxServe sales of non-Sanofi products are included in Other revenues from 2016 onwards. The presentation of prior period Net sales and Other revenues has been amended accordingly.

Open this statistic in...
Revenue of Sanofi 2006-2018
Sanofi is a global leader in healthcare and pharmaceuticals based in Paris, France. In 2018, Sanofi generated about 34.5 billion euros in revenues. Sanofi’s modern revenues were highest in 2017 when the company earned just over 35 billion euros. In general, the company’s revenues have been increasing since 2006 when their revenues were 28.4 billion euros.

Sanofi’s company profile

Sanofi is a one of the world’s leading pharmaceutical companies and its subsidiaries include Genzyme, Sanofi Pasteur and Aventis Pharma, to name a few. Sanofi is ranked among the top ten global pharmaceutical companies based on market capitalization. Likewise, the company is ranked among the top six global pharmaceutical companies based on its prescription sales.

Sanofi’s products and revenues

Sanofi works in several therapeutic sectors including health and wellbeing, diabetes and cardiovascular diseases, oncology, immunology, multiple sclerosis, rare diseases, rare blood disorders, and vaccines. A majority of Sanofi’s revenues can be attributed to their pharmaceutical sector. Sanofi’s top pharmaceutical products, based on revenues include Lantus, Aubagio and Lovenox. Lantus is a long-acting insulin for use in type I and type II diabetes. Sanofi also used to have an animal health sector but the business was sold to Boehringer Ingelheim in 2016.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Sanofi
Sanofi

All Information
in one Presentation

Sanofi

Everything On "Sanofi" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Sanofi"
  • Global positioning
  • Overview
  • Revenue distribution
  • Company shares
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.